Latest news
Guggenheim Downgrades Roku to Neutral From Buy, Adjusts PT to $160 From $145 - MoomooMoomoo · Fri, 07 Aug 2026 15:33:15 GMTGuggenheim Adjusts Price Target on Pfizer to $31 From $35, Maintains Buy Rating - MoomooMoomoo · Fri, 07 Aug 2026 10:45:52 GMTGuggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $70 - MoomooMoomoo · Wed, 05 Aug 2026 12:35:00 GMTGuggenheim Adjusts Price Target on First Solar to $282 From $279, Maintains Buy Rating - MoomooMoomoo · Mon, 03 Aug 2026 14:13:10 GMTGuggenheim Adjusts Price Target on Bristol-Myers Squibb to $75 From $72, Maintains Buy Rating - MoomooMoomoo · Fri, 31 Jul 2026 15:10:19 GMTGuggenheim Adjusts Price Target on Cigna Group to $361 From $338, Maintains Buy Rating - MoomooMoomoo · Fri, 31 Jul 2026 12:36:42 GMTGuggenheim Adjusts Price Target on Meta Platforms to $700 From $800, Maintains Buy Rating - MoomooMoomoo · Thu, 30 Jul 2026 09:45:48 GMT